Search research articles
Contact Us
Filters
Showing results (191-200 of 218) with videos related to
Page
of 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice
Ruth M O'Regan, Clodia Osipo, Eric Ariazi, et al.
Cancer Research
|
July 20, 2006
Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells
Jeong-Seok Nam, Mi-Jin Kang, Adam M Suchar, et al.
Cancer Research
|
August 3, 2002
Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor
Anait S Levenson, Kristen M Svoboda, Katherine M Pease, et al.
Journal of the National Cancer Institute
|
November 6, 2003
Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo
Hong Liu, Eun-Sook Lee, Csaba Gajdos, et al.
Cancer Research
|
December 3, 2005
MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis
Anait S Levenson, Kenneth E Thurn, Laura A Simons, et al.
The Journal of Biological Chemistry
|
December 26, 2001
Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells
Hong Liu, Woo-Chan Park, David J Bentrem, et al.
Pharmacological Reviews
|
November 30, 2006
International Union of Pharmacology. LXIV. Estrogen receptors
Karin Dahlman-Wright, Vincent Cavailles, Suzanne A Fuqua, et al.
Biochemical Pharmacology
|
March 19, 2013
5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells
Gregory Segala, Philippe de Medina, Luigi Iuliano, et al.
Exploration of Targeted Anti-Tumor Therapy
|
November 19, 2020
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer
Milene Volpato, Michele Cummings, Abeer M Shaaban, et al.
Plos One
|
July 9, 2011
Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells
Zhang-Zhi Hu, Benjamin L Kagan, Eric A Ariazi, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 218) with videos related to
Sort By:
Page
of 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice
Ruth M O'Regan, Clodia Osipo, Eric Ariazi, et al.
Cancer Research
|
July 20, 2006
Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells
Jeong-Seok Nam, Mi-Jin Kang, Adam M Suchar, et al.
Cancer Research
|
August 3, 2002
Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor
Anait S Levenson, Kristen M Svoboda, Katherine M Pease, et al.
Journal of the National Cancer Institute
|
November 6, 2003
Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo
Hong Liu, Eun-Sook Lee, Csaba Gajdos, et al.
Cancer Research
|
December 3, 2005
MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis
Anait S Levenson, Kenneth E Thurn, Laura A Simons, et al.
The Journal of Biological Chemistry
|
December 26, 2001
Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells
Hong Liu, Woo-Chan Park, David J Bentrem, et al.
Pharmacological Reviews
|
November 30, 2006
International Union of Pharmacology. LXIV. Estrogen receptors
Karin Dahlman-Wright, Vincent Cavailles, Suzanne A Fuqua, et al.
Biochemical Pharmacology
|
March 19, 2013
5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells
Gregory Segala, Philippe de Medina, Luigi Iuliano, et al.
Exploration of Targeted Anti-Tumor Therapy
|
November 19, 2020
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer
Milene Volpato, Michele Cummings, Abeer M Shaaban, et al.
Plos One
|
July 9, 2011
Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells
Zhang-Zhi Hu, Benjamin L Kagan, Eric A Ariazi, et al.
Page
of 22